Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Gyongyos – page 5

109 clinical trials in Gyongyos, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Gyongyos at a glance
109
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

109 trials in Gyongyos

Open in trial search
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
  • Sponsor:Novartis Pharma AG
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Institut De Recherches Internationales Servier IRIS
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Isis 678354 Sodium Salt
  • Sponsor:Ionis Pharmaceuticals Inc.
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Amg 193
  • Sponsor:Amgen Inc.

Psoriasis

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ly4100511
  • Sponsor:DICE Therapeutics Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Hungary

The busiest research cities in the country

All 70 cities in Hungary

Clinical research in Gyongyos

What the registry says about research in the country

01 Respiratory Diseases

Research focusing on innovative treatments for non-small cell lung cancer (NSCLC) and chronic respiratory conditions, with multiple trials evaluating new immunotherapy combinations and targeted therapies.

  • Advanced NSCLC Treatment Studies
  • COPD Management Research
  • Idiopathic Pulmonary Fibrosis Studies

Several trials are exploring combination therapies to improve patient outcomes in advanced stages of lung cancer.

02 Autoimmune Conditions

Comprehensive studies on inflammatory and autoimmune disorders, including psoriasis and inflammatory bowel diseases, testing novel therapeutic approaches.

  • Plaque Psoriasis Treatments
  • Ulcerative Colitis Therapies
  • Crohn's Disease Management

Multiple trials are evaluating new biological therapies for moderate to severe cases of these conditions.

03 Cardiovascular Research

Innovative studies targeting heart failure prevention and cardiovascular disease management, with a focus on reducing major adverse cardiac events.

  • Heart Failure Prevention
  • Atherosclerotic Disease
  • Cardiovascular Risk Management

Research includes novel therapeutic combinations and preventive strategies for high-risk patients.

04 Neurological Disorders

Clinical research focusing on Alzheimer's Disease and associated conditions, particularly investigating treatments for psychosis symptoms.

  • Alzheimer's-Related Psychosis
  • Cognitive Function Studies

Trials are evaluating new therapeutic approaches for managing neuropsychiatric symptoms.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.